A retrospective matched cohort study on the association between herpes zoster vaccination and dementia and mild cognitive impairment using electronic health records (ZOSTER-122 AIML 222419)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/108337
• EU PAS number:
  EUPAS107206
• Study ID:
  108337
• Official title and acronym:
  A retrospective matched cohort study on the association between herpes zoster vaccination and dementia and mild cognitive impairment using electronic health records (ZOSTER-122 AIML 222419)
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  A study to determine the association between herpes zoster (HZ) vaccination and dementia and mild cognitive impairment using electronic health records.
• Study status:
  Ongoing

Research institutions and networks

Institutions

GlaxoSmithKline (GSK)

Study timelines

Date when funding contract was signed

Planned: 13/10/2023

Actual: 13/10/2023

Study start date

Planned: 24/10/2023

Actual: 24/10/2023

Date of final study report

Planned: 31/07/2025

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

GlaxoSmithKline

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable